The American Diabetes Association (ADA) recognizes the cardiovascular benefits of GLP-1 receptor agonists in their Standards of Care but does not currently recommend these agents solely for inflammation management outside established indications for diabetes, obesity, or cardiovascular risk reduction
If they work, we've found a new treatment pathway that doesn't require IV infusions or brain scans to monitor for swelling
81,83,84 Mentha piperita (Peppermint) is a powerful spasmolytic agent
[3] Tirzepatide is administered once weekly via subcutaneous injection and works by enhancing insulin secretion in response to meals, suppressing glucagon release, slowing gastric emptying, and reducing appetitemechanisms that collectively improve glycaemic control and promote weight loss
Understanding how GLP-1 functions and becoming more cognizant of it in everyday nutrition and exercise can lead to significant improvements in health and longevity
13, 2026 Prescriptions as needed Renew or get a new Rx